ImmuneOnco clarifies subsidiary capital increase as employee incentive scheme via ESOP platformPUBT·2 days ago, 07:18 AM01541+3.17%
The Tech Giants' AI Rush Is Masking a Severe Fracture in Hong Kong's MarketGlobal Report·Jul 30 at 04:14 AM09609+0.49%80700+3.28%
ImmuneOnco files HKEX next-day disclosure return reporting share repurchase for treasury sharesPUBT·Jul 24 at 06:03 AM01541+3.17%
ImmuneOnco files HKEX next-day disclosure return on share repurchase cancellationPUBT·Jul 23 at 05:28 AM01541+3.17%
S.F. Holding files HKEX next-day disclosure return on share repurchase for cancellationPUBT·Jul 22 at 04:18 AM06936+0.18%002352+0.17%
Hong Kong Cross-Sector Moves: Key Catalysts for 10 Equities From Biotech to IndustrialsGlobal Report·Jul 21 at 04:13 AM01963-0.93%01898-1.77%
ImmuneOnco files HKEX next-day disclosure return after share repurchase at HKD 3.59-3.39PUBT·Jul 17 at 06:13 AM01541+3.17%
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Receives a Buy from Guoyuan Securities (HK)Tip Ranks·Jul 11 at 09:45 AM01541+3.17%
ImmuneOnco Starts Phase II/III Trial of First-in-Class IMM0306 for IgG4-Related DiseaseTip Ranks·Jul 9 at 11:37 PM01541+3.17%
ImmuneOnco files HKEX next-day disclosure return after share repurchasePUBT·Jul 8 at 07:33 AM01541+3.17%
ImmuneOnco Biopharma files HKEX next-day disclosure return on share buybackPUBT·Jul 7 at 06:33 AM01541+3.17%
ImmuneOnco files HKEX next-day disclosure return after share repurchase at HKD 3.87PUBT·Jul 3 at 04:59 AM01541+3.17%
STOCKS | Yimeng OncoBio Says HKEX Questions Loan Exemption; Independent Approval NeededCoinLive·Jul 2 at 10:37 AM01541+3.17%
ImmuneOnco Dilutes Stake in Subsidiary via De Minimis Connected Capital InjectionTip Ranks·Jun 18 at 09:44 AM01541+3.17%
ImmuneOnco unit Jiaxing Changxin subscribes RMB 325,000 in subsidiary, takes 20% stakePUBT·Jun 18 at 09:07 AM01541+3.17%
